Shots: The P-III LUSTER-1 & 2 studies involve assessing of Fevipiprant (150/ 450mg) vs PBO in 894 & 877 patients aged ≥12yrs. in a ratio (1:1:1) with moderate-severe asthma, receiving […]readmore
Tags : GINA 4/5 Asthma